MedTrace Logo

Genicular RFT vs Phenol Management in Patients With Knee Osteoarthritis

NCT05908942 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 64

Last updated 2023-06-18

No results posted yet for this study

Summary

The aim of this study was to compare the efficacy of phenol and radiofrequency ablation for genicular nerve neurolysis in severe knee pain. The invesigators compare the efficacy of radiofrequency and phenol applications on numerical pain score and Western Ontario and McMaster Universi- ties Osteoarthritis Index (WOMAC) before, 1 and 3 months after the procedure. The procedures will be performed by applying radiofrequency waves and phenol to the genicular nerves under ultrasound guidance.

Conditions

  • Knee Pain Chronic

Interventions

DEVICE

Nerve ablation

radiofrequency and phenol ablation of the genicular nerves will be performed

Sponsors & Collaborators

  • Diskapi Teaching and Research Hospital

    lead OTHER

Principal Investigators

  • Gevher R Genç Perdecioğlu · Diskapi TRH

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2023-04-01
Completion
2023-06-30
FDA Device
Yes

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05908942 on ClinicalTrials.gov